Immune Microenvironment Characterized in Multiple Myeloma Progression
By LabMedica International staff writers Posted on 30 Nov 2022 |
Multiple myeloma (MM) is a malignant disease of plasma cells (PCs) that reside within the bone marrow (BM). Early alterations within the bone marrow microenvironment that contribute to the progression of MM from its precursor stages could be the key to identifying novel therapeutic approaches.
The disease transitions from the precursor stages, monoclonal gammopathy of undetermined significance (MGUS) and smoldering MM (SMM), to clinically aggressive disease. Although the outcomes have improved, the disease remains largely incurable once progression has occurred.
Clinical Scientists at the University of Arkansas for Medical Sciences (Little Rock, AR, USA) and their international colleagues collected primary BM and peripheral blood (PB) samples were from nine patients with MGUS, seven with SMM, and 10 with newly diagnosed MM (NDMM). CD138-depleted BM samples were viably frozen in dimethyl sulfoxide at a final concentration of 10% and processed for single-cell RNA sequencing (scRNA-seq) and T-cell receptor (TCR) sequencing.
The team used single-cell RNA sequencing of bone marrow cells with the 10× Genomics Single Cell 5′ version kit (Pleasanton, CA, USA) that was performed on the PC-depleted mononuclear fraction of BM aspirates from patients. Single-cell capture (target, 3,000 cells), reverse transcription, library preparation (expression and TCR), and paired-end sequencing were performed. All BM samples were further investigated by eight color flow cytometry using CD138, CD38, CD45, CD19, CD56, CD20, CD27, and CD81 to distinguish B-, T-, NK-, and immature B-cell subsets as well as monocytes. Preprocessing of the 10× scRNA-seq and TCR data was performed with CellRanger.
The scientists identified changes in immune cell populations as the disease progressed, which were characterized by a substantial decrease in memory and naïve CD4 T cells, and an increase in CD8+ effector T cells and T-regulatory cells. These alterations were further accompanied by an enrichment of nonclonal memory B cells and an increase in CD14 and CD16 monocytes in MM compared with its precursor stages. T cells were by far the largest subpopulation with 27,621 of the total 62,044 cells (44.5%) and were clustered into 10 distinct T-cell subpopulations. T cells were divided into two main clusters, consisting of CD4 and CD8 T cells. B cells were divided into naïve B cells and Memory B cells.
The investigators reported that memory B cells showed a striking expansion from MGUS to NDMM in both data sets and the meta-analysis. Alterations were further accompanied by an enrichment of nonclonal memory B cells and an increase in CD14 and CD16 monocytes in MM compared with its precursor stages.
The authors concluded that their results provide crucial information on the immune changes associated with the progression to clinical MM and can help to develop immune-based strategies for patient stratification and early therapeutic intervention. The study was published on November 22, 2022 in the journal Blood Advances.
Related Links:
University of Arkansas for Medical Sciences
10× Genomics
Latest Hematology News
- Next Generation Instrument Screens for Hemoglobin Disorders in Newborns
- First 4-in-1 Nucleic Acid Test for Arbovirus Screening to Reduce Risk of Transfusion-Transmitted Infections
- POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy
- First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy
- Handheld White Blood Cell Tracker to Enable Rapid Testing For Infections
- Smart Palm-size Optofluidic Hematology Analyzer Enables POCT of Patients’ Blood Cells
- Automated Hematology Platform Offers High Throughput Analytical Performance
- New Tool Analyzes Blood Platelets Faster, Easily and Accurately
- First Rapid-Result Hematology Analyzer Reports Measures of Infection and Severity at POC
- Bleeding Risk Diagnostic Test to Reduce Preventable Complications in Hospitals
- True POC Hematology Analyzer with Direct Capillary Sampling Enhances Ease-of-Use and Testing Throughput
- Point of Care CBC Analyzer with Direct Capillary Sampling Enhances Ease-of-Use and Testing Throughput
- Blood Test Could Predict Outcomes in Emergency Department and Hospital Admissions
- Novel Technology Diagnoses Immunothrombosis Using Breath Gas Analysis
- Advanced Hematology System Allows Labs to Process Up To 119 Complete Blood Count Results per Hour
- Unique AI-Based Approach Automates Clinical Analysis of Blood Data